transparent gif


Ej inloggad.

Göteborgs universitets publikationer

Both low and high serum igf-I levels associate with cancer mortality in older men.

Författare och institution:
Johan Svensson (Centre for Bone and Arthritis Research); Daniel Carlzon (Centre for Bone and Arthritis Research); Max Petzold (Akademistatistik); Magnus Karlsson (-); Osten Ljunggren (-); Åsa Tivesten (Wallenberglaboratoriet); Dan Mellström (Centre for Bone and Arthritis Research); Claes Ohlsson (Centre for Bone and Arthritis Research)
Publicerad i:
The Journal of clinical endocrinology and metabolism, 97 ( 12 ) s. 4623-30
Artikel, refereegranskad vetenskaplig
Sammanfattning (abstract):
Background: Although recent population-based studies suggest a U-shaped relationship between serum IGF-I concentration and all-cause mortality, the distribution of death causes underlying this association remains unclear. We hypothesized that high IGF-I levels associate with increased cancer mortality, whereas low IGF-I levels associate with increased cardiovascular disease (CVD) mortality. Methods: Serum IGF-I levels were measured in 2901 elderly men (mean age 75.4, range 69-81 yr) included in the prospective population-based Osteoporotic Fractures in Men Study (Sweden) study. Mortality data were obtained from central registers with no loss of follow-up. The statistical analyses included Cox proportional hazards regressions with or without a spline approach. Results: During the follow-up (mean 6.0 yr), 586 of the participants died (cancer deaths, n = 211; CVD deaths, n = 214). As expected, our data revealed a U-shaped association between serum IGF-I levels and all-cause mortality. Low as well as high serum IGF-I (quintile 1 or 5 vs. quintiles 2-4) associated with increased cancer mortality [hazard ratio (HR) = 1.86, 95% confidence interval (CI) = 1.34-2.58; and HR = 1.90, 95% CI = 1.37-2.65, respectively]. Only low serum IGF-I associated with increased CVD mortality (quintile 1 vs. quintiles 2-4, HR = 1.48, 95% CI = 1.08-2.04). These associations remained after adjustment for multiple covariates and exclusion of men who died during the first 2 yr of follow-up. Conclusions: Our findings demonstrate that both low and high serum IGF-I levels are risk markers for increased cancer mortality in older men. Moreover, low IGF-I levels associate with increased CVD mortality.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
Klinisk medicin ->
Endokrinologi och diabetes ->
Klinisk medicin ->
Postens nummer:
Posten skapad:
2013-01-14 10:35
Posten ändrad:
2014-01-07 16:06

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007